95 results
POS AM
QNRX
Quoin Pharmaceuticals Ltd
29 Mar 24
Prospectus update (post-effective amendment)
4:11pm
with regulatory standards and requirements and insider trading.
We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees … to the FDA and non-U.S. regulators, to comply with healthcare fraud and abuse laws and regulations in the United States and abroad, to report financial
424B3
8g2mdecte6
8 Mar 24
Prospectus supplement
4:06pm
424B3
244y9r 2cm801zekj
8 Mar 24
Prospectus supplement
4:04pm
8-K
EX-10.1
v213sz0
8 Mar 24
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies
4:01pm
424B4
e8vz 5t9yern7p
6 Mar 24
Prospectus supplement with pricing info
5:07pm
424B3
jzh6 d45q
4 Mar 24
Prospectus supplement
5:27pm
424B3
e94m7eoq71k9g 80
31 Jan 24
Prospectus supplement
12:00am
8-K
EX-10.1
6f9ne17h pj1rx9
30 Jan 24
Entry into a Material Definitive Agreement
4:05pm
424B3
3r37 u6xcbd
9 Nov 23
Prospectus supplement
5:15pm
424B3
o33y327y
14 Sep 23
Prospectus supplement
4:38pm